Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-10

Clinical Trial Update: Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temsirolimus alone or with dexamethasone delivered to the adventitia to enhance clinical efficacy after femoropopliteal revascularizati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decadron (Dexamethasone)
  • Torisel (Temsirolimus)

Snippet

Sponsor: Mercator MedSystems, Inc. | Conditions: Peripheral Arterial Disease | Phase 2 | Status: TERMINATED